Safety and Efficacy of Encapsulated Allogeneic MPS-1 Therapy

NCT05665036 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Sponsor developing new product

Conditions

Interventions

Sponsor

Sigilon Therapeutics, Inc.